Kelemenis advises Stryker, one of the world’s leading medical technology companies, on the Greek law of agency

The firm has been instructed by Stryker to advise its Swiss subsidiary on an exclusive distribution agreement governed by Greek law. Kelemenis & Co is advising the client on the application of Greek law and in particular on the harmonization of Council Directive 86/653/EEC of 18 December 1986 on the coordination of the laws of the Member States relating to self-employed commercial agents and its application to exclusive distributors. Stryker is one of the world’s leading medical technology companies. It currently has over 20,000 employees worldwide and revenues exceeding USD 7.5 billion.